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Abstract
This dissertation focuses on studying methods in dependence structure analysis. In
particular, it consists of two topics: (1) modeling dynamic correlation in zero-inflated
bivariate count data; and (2) gene co-expression latent factor analysis for cell-type
clustering.
In Chapter 2, a zero-inflated negative binomial model for analyzing the dynamic
correlation in zero-inflated bivariate count data is proposed. Interactions between
biological molecules in a cell are tightly coordinated and often highly dynamic. As a
result of these varying signaling activities, changes in gene co-expression patterns
could often be observed. The advancements in next-generation sequencing technologies bring new statistical challenges for studying these dynamic changes of gene
co-expression. In recent years, methods have been developed to examine genomic
information from individual cells. Single-cell RNA sequencing (scRNA-seq) data
are count-based, and often exhibit characteristics such as over-dispersion and zeroinflation. To explore the dynamic dependence structure in scRNA-seq data and other
zero-inflated count data, new approaches are needed. We consider over-dispersion
and zero-inflation in count outcomes and propose a ZEro-inflated Negative binomial
dynamic COrrelation model (ZENCO). The observed count data are modeled as a
mixture of two components: success amplifications and dropout events in ZENCO. A
latent variable is incorporated into ZENCO in order to model the covariate-dependent
correlation structure. We conduct simulation studies to evaluate the performance of
our proposed method and to compare it with existing approaches. We also illustrate
the implementation of our proposed approach using scRNA-seq data in melanoma.
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Chapter 3 proposes a cell-type clustering approach that allows for joint analysis of both expression structures and co-expression structures of the data. Due to
the complex regulatory mechanisms, biological molecules in a cell often participate in
complicated interaction processes. The traditional cell-type clustering approaches use
average expression levels of the data and are therefore insufficient for understanding
the intricate regulatory mechanisms that underlie different cellular conditions. The
co-expression structures can often bring insights into the complex genetic interactions
and can help detect correlation changes between pairs of genes across different modulating conditions. Therefore, the co-expression structures can help identify hidden
sub-groups in the data and improve the performance of clustering. Our method learns
the joint features shared among expression structures and co-expression structures of
the data and identifies the unique variation present in each type of structure to further cluster the cell types. The proposed approach is applied to a breast cancer cells
data set.
In Chapter 4, a subject-specific random effects model for zero-inflated count-based
data is proposed. Tumor heterogeneity is very common and plays important role in
therapy design. The development of scRNA-seq technologies brings new opportunities
along with challenges for studying tumor heterogeneity. For scRNA-seq data, one of
the main analytical approaches is differential co-expression analysis, which can reveal
the intricate underlying gene regulatory mechanisms in tumor cells. In recent years,
methods have been developed for modeling the dynamic changes of gene co-expression
in scRNA-seq data. However, due to the heterogeneous nature of tumors, new approaches are needed. In this chapter, we propose a subject-specific random effects
model for zero-inflated count-based data such as scRNA-seq data. A latent variable
is incorporated into the model to quantify the correlation dependency structure. We
conduct simulation studies to evaluate the performance of our proposed method and
to compare it with existing approaches. We also illustrate the implementation of our
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proposed approach using scRNA-seq data from a study of immunotherapy resistance
in melanoma tumors.
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Chapter 1
Introduction
1.1

Introduction

Analysis for dependence structures or dynamic correlation patterns between random
quantities is one of the most crucial topics in both statistical theory and genomic
applications. In this section, we briefly review the approaches and challenges in the
study of dynamic correlation.
Interactions between biological molecules in a cell are tightly coordinated and
often highly dynamic (Luscombe et al., 2004; de Lichtenberg et al., 2005). They can
change flexibly under different cellular conditions or in response to various external
stimulants and signals. As a result of these varying signaling activities, changes
in gene co-expression patterns can often be observed in these situations (Li, 2002;
Li and Yuan, 2004; de la Fuente, 2010a). Studying these dynamic changes in gene
co-expression could reveal these intricate underlying gene regulatory mechanisms.
While it is a challenging task to unravel the complex genetic interactions in a
biological system, several statistical approaches have been introduced to describe the
co-expression between a pair of genes such as Pearson correlation or rank correlation, F-statistic (Lai et al., 2004), mutual information (Faith et al., 2007), entropybased approaches (Ho et al., 2007), Gaussian graphical models (Ma et al., 2007), and
Bayesian network (Ho et al., 2014). However, these approaches do not account for
the fact that genetic circuits can be turned on or off and genes may participate in
different regulatory processes under different cellular conditions.
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One statistical measure that can capture these dynamic gene correlation changes
was proposed by Li (2002). This measure, named dynamic correlation in this paper,
quantifies the relationship where the co-expression between two genes is modulated
by a third "coordinator" gene. Li (2002) examined these dynamic correlation changes
(referred to as liquid association in his paper) in canonical pathways using microarray gene expression data from a model organism, Saccharomyces cerevisiae. For a
typical genomic study, a pathway-based or a genome-wide screening strategy can be
implemented as presented in several studies to effectively identify potential dynamic
correlation changes (Dawson and Kendziorski, 2012; Gunderson and Ho, 2014; Wang
et al., 2017; Yu, 2018; Kinzy et al., 2019). Li’s study and other studies since then,
have evidently established its biological validity and popularized it to be a useful tool
for analyzing genomic data (Li, 2002; Li et al., 2004; Ho et al., 2007; Zhang et al.,
2007; Ho et al., 2011; Wang et al., 2013; Xu et al., 2017; Wang et al., 2017; Khayer
et al., 2017; Ai et al., 2019; Kong and Yu, 2019; Wen et al., 2020).
However, when it comes to count data such as RNA sequencing reads, these existing Gaussian-based approaches may not fit the data properly. RNA sequencing
(RNA-seq) data are often presented as a count matrix with non-negative counts as
the number of reads observed. Count-based models such as the Poisson distribution and the negative binomial distribution are widely used to analyze the RNA-seq
data. Karlis and Meligkotsidou (2005) proposed a multivariate Poisson model with
covariance structure. Due to both biological and technical variability, RNA-seq count
data are often over-dispersed. For over-dispersed data, the variance is larger than the
mean, which is a violation of the assumption of the Poisson distribution (mean and
variance are equal). To handle over-dispersion, Solis-Trapala and Farewell (2005)
used a multivariate Poisson-Gamma mixture model. Robinson et al. (2010) modeled
the data using the negative binomial distribution and treated the Poisson distribution as a special case of the negative binomial distribution. Ma et al. (2020) proposed
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three flexible Bayesian regression approaches for modeling bivariate correlated count
data.
In recent years, the rapid development of next-generation sequencing technologies has made it possible to examine the sequence information from individual cells.
Single-cell RNA sequencing (scRNA-seq) analyzes the expression of RNAs from individual cells, while traditional RNA-seq can only analyze the RNAs from mixed cell
populations (Bacher and Kendziorski, 2016; Hwang et al., 2018). scRNA-seq gives
insight into individual cells’ function and behavior at various stages and in various
cell types and hence can provide a high-resolution view of dynamic co-expression
regulation in a biological system.
However, the analysis of scRNA-seq data is complicated by high levels of technical
noise and intrinsic biological variability (Kharchenko et al., 2014). Due to the low
amounts of mRNA within individual cells, the counts of single-cell gene expression
data contain a large number of zero expression measurements. To avoid stochastic
zero counts, Lun et al. (2016) developed a normalization method based on pooling expression values. Pierson and Yau (2015) developed a dimensionality-reduction
method considering the dropout characteristics to improve modeling accuracy. Miao
et al. (2018) used a zero-inflated negative binomial model to estimate the proportion
of real and dropout zeros. Kharchenko et al. (2014) modeled the measurement of
each cell as a mixture of two components: one for transcripts that are successfully
detected and the other for dropout events during amplification.

1.2

Background Concept

In this section we review the concept of liquid association which will appear in later
chapters.
Liquid association is a statistical measure that quantifies the relationship between
the correlation of two genes (Xi , Xj ) and the expression level of third gene (Z).
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Suppose that three random variables Xi , Xj , and Z represent the expression levels
of three genes and are already standardized to have mean 0 and variance 1. We can
regard the entry-wise product of Xi and Xj as the co-expression measure between
them. So the correlation coefficient between Xi and Xj is E(Xi Xj ). By conditioning
on Z,
E(Xi Xj ) = E(E(Xi Xj |Z)) = Eg(Z),

(1.1)

where g(Z) = E(Xi Xj |Z) is the conditional correlation of Xi and Xj given Z. Then
the liquid association of Xi and Xj with respect to Z is defined as
LA(Xi , Xj |Z) = Eg ′ (Z),

(1.2)

where g ′ (X) is the derivative of g(X) with respective to X. Furthermore, when Z
follows a standard normal distribution, LA(Xi , Xj |Z) = Eg ′ (Z) is equal to a threeproduct-moment estimator E(Xi Xj Z).
In the above setting of liquid association, the variable Z is given. Oftentimes, Z
represents the pathway activities and cannot be measured directly. To estimate the
latent variables Z, Yu (2018) uses a new vector h which is the element-wise product
of Xi and Xj . For any gene pair, a product vector h can be calculated. We then
construct a product matrix Xprod , each row of which being a product vector h of a
gene pair to represent the co-expression structures of the data. For a product matrix
with m rows, Yu (2018) shows that, by applying eigenvalue decomposition to the
′
matrix Xprod
Xprod , the latent factors Zk , k = 1, ..., K that regulate the coexpression

structures of the data can be obtained from
zk = argmax||z||=1

(z · h)2 , zs ′ zt = 0, s ̸= t.

X

(1.3)

m

1.3

Structure of the dissertation proposal

The rest of the dissertation proposal is organized as follows. In Chapter 2, we propose a zero-inflated negative binomial model for studying dynamic correlation in
4

zero-inflated, over-dispersed count data, such as scRNA-seq data. In Chapter 3, we
propose a cell-type clustering approach that allows for joint analysis of both expression structures and co-expression structures of the data. In Chapter 4, we propose a
subject-specific random effects model which incorporates between-individual random
effects to account for the variation of cells collected from different participants.

5

Chapter 2
Modeling Dynamic Correlation in Zero-inflated
Bivariate Count Data
2.1

Introduction

Motivated by the dynamic correlation studies in microarray data, in this chapter, we
propose the ZEro-inflated Negative binomial dynamic COrrelation (ZENCO) model.
We account for over-dispersion and zero-inflation in count data by considering a mixture model of conditional bivariate negative binomial regressions and zero counts. A
latent variable is incorporated into ZENCO to model the covariate-dependent correlation structure. We demonstrate the implementation of ZENCO model using the
scRNA-seq data of melanoma cells from Gene Expression Omnibus (GSE116237) and
study the difference of dynamic correlations between various phases during treatment
with BRAF/MEK inhibitors.
The remainder of the chapter is arranged as follows. In Section 2.2, the detail
of the proposed model is introduced. The simulation studies and comparisons are
conducted in Section 2.3. In Section 2.4, the analysis of scRNA-seq data generated
from melanoma tumor cells is presented. Section 2.5 concludes this chapter with
some discussion.

6

2.2

Method

2.2.1

The ZENCO model

For modeling dynamic co-expression changes, we use X1 , X2 , and X3 to denote
the count-based expression levels for three genes. Let Xij represent the gene expression level of the ith gene (i = 1, 2, 3) in the jth cells (j = 1, 2, ...n), and
Xi = (Xi1 , Xi2 , Xi3 , ..., Xin ) represents the gene expression level for the ith gene.
In our proposed framework, the marginal distribution of Xi is modeled as a mixture
of dropout component and negative binomial component (non-dropout events). The
distribution of Xi is given by
Xi ∼




I

with probability pi ;

0,



N B(µi , ϕi ),

(2.1)

with probability 1 − pi .

where I0 is the distribution with a point mass at zero; pi is the dropout rate of
Xi ; µi is the mean of the negative binomial component of Xi and ϕi is the dispersion
parameter of the negative binomial component. The variance of the negative binomial
component of Xi is µi (1 + ϕi µi ). As ϕi goes to 0, N B(µi , ϕi ) → P oisson(µi ).
The dropout rate of a given gene, pi , is modeled as a function of its mean. The
dropout rates are study-specific and can be estimated for a given scRNA-seq dataset.
Based on the melanoma data considered in the study, we model the dropout rate
using a logistic function: p =

e(b0 +b1 µ)
1+e(b0 +b1 µ)

, where µ is the mean of a given gene and

b0 , b1 can be estimated using the expression levels of all available genes in the data
(Pierson and Yau, 2015).
Furthermore, we use the indicator dij ∼ Bernoulli(pi ) to describe whether dropout
happens or not. If dij = 0, then the ith gene in the jth cell is successfully amplified
(non-dropout event). If dij = 1, then dropout happens. According to the combinations of different values of d1j and d2j , there are four different situations for X1 and
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X2 . Their marginal densities can be written as:




X1j







X
1j




X1j







X1j

∼ N B(µ1 , ϕ1 ) and X2j ∼ N B(µ2 , ϕ2 ), if d1j = d2j = 0;
∼ I0 and X2j ∼ N B(µ2 , ϕ2 ),

if d1j = 1 and d2j = 0;

∼ N B(µ1 , ϕ1 ) and X2j ∼ I0 ,

if d1j = 0 and d2j = 1;

∼ I0 and X2j ∼ I0 ,

if d1j = d2j = 1.

(2.2)

When d1j = d2j = d3j = 0, the joint distribution of X1 and X2 involves a correlation
parameter that depends on the expression level of X3j . In other words, the correlation
between X1j and X2j could change according to the level of X3j when all three genes
(X1j , X2j and X3j ) are successfully amplified in the jth cell. If d1j =1 or d2j = 1, X1j
and X2j are independent, because at least one measurement of X1j and X2j comes
from the dropout component.
We model the dependency between X1 and X2 and construct our conditional
bivariate negative binomial model through a Poisson-Gamma mixture distribution.
For i = 1, 2 and j = 1, 2, ..., n, let
Xij ∼ P oisson(uij µi ), uij ∼ Gamma(αi , αi ).

(2.3)

A negative binomial distribution of N B(µi , α1i ) can be generated by integrating over
uij in (2.3). In this Poisson-Gamma mixture setting, uij can be considered as the
cell-specific random effect. To introduce the conditional correlation between X1j and
X2j given X3j , we utilize a latent variable Z and model the conditional correlation
implicitly through the cell-specific random effect (uij ).
Let Zj = (Z1j , Z2j )′ be a bivariate normal variable that
  
0  1
 
N2 
 ,



ρj  
 .

1

(2.4)

1 + ρj
) = τ0 + τ1 X3j .
1 − ρj

(2.5)

Zj ∼



0

ρj

The correlation, ρj , of (Z1j , Z2j ) is specified as
log(
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j
log( 1+ρ
) is the Fisher’s Z-transformation for the correlation ρj which ensures the
1−ρj

correlation ρj is within (-1, 1).
Now, we incorporate this latent variable Zj into the cell-specific random component (uij ) in the Poisson-Gamma mixture in (2.3) to construct a conditional bivariate
negative binomial model of (X1j , X2j )′ with marginal distribution X1j ∼ N B(µ1 , ϕ1 )
and X2j ∼ N B(µ2 , ϕ2 ) and the correlation of (X1j , X2j ) depends on X3j . Specifically,
for i = 1, 2 and j = 1, 2, ..., n, let
Xij ∼ P oisson[Fα−1
{Φ(Zij )}µi ],
i

(2.6)

where Fαi (·) is the cumulative distribution function of a Gamma(αi , αi ) distribution
with αi = 1/ϕi and Φ(·) is the cumulative distribution function of a standard normal
maps each point in the interval (0,1) to Gamma(αi , αi ) distribudistribution. Fα−1
i
{Φ(Zij )} is Gamma(αi , αi ). The distribution of
tion. Hence, the distribution of Fα−1
i
{Φ(Zij )}µi ] is then a Poisson-Gamma mixture distribution, which
Xij ∼ P oisson[Fα−1
i
follows the negative binomial density N B(µi , ϕi =

1
).
αi

In the model described above, in order to determine the existence of the dynamic
co-expression change of X1 , X2 given X3 , the main parameter of interest is τ1 in
(2.5). If τ1 =0, then the correlation between X1 and X2 does not depend on X3 and
vice versa. In the ZENCO model, we develop a statistical inference procedure via a
Bayesian perspective, because it offers a relatively straightforward way to compute
P oisson[Fα−1
{Φ(Zij )}] through Markov Chain Monte Carlo (MCMC) sampling. In
i
addition, the posterior distributions of the parameters can be obtained with a set of
standard conjugate priors.
Under the hypotheses:
H0 : τ1 = 0 versus H1 : τ1 ̸= 0,
the statistical power of the proposed ZENCO approach can be calculated as follows.
First, we obtained the posterior sampling distribution of τ1 , then calculated the 95%
9

equal tail credible interval. Power can be evaluated as the proportion of times when
zero is not covered by the 95% credible intervals.
We now describe the likelihood function and the MCMC scheme. Let vector θ be
the notation of all parameters (µ1 , µ2 , µ3 , ϕ1 , ϕ2 , ϕ3 , τ0 , τ1 ) in the model. And let
π (θθ ) be the prior joint distribution of θ , the likelihood function is given by
L(θθ |x1 , x2 , x3 ) =
=

n
Y

f (x1j , x2j |µ1 , µ2 , ϕ1 , ϕ2 , τ0 , τ1 , x3j )f (x3j |µ3 , ϕ3 )

j=1
n Z
Y



f (x1j , x2j |µ1 , µ2 , ϕ1 , ϕ2 , z j )f (zz j |x3j , τ0 , τ1 )dzz j f (x3j |µ3 , ϕ3 )

j=1

=

n Z Y
2
Y
j=1



f (xij |µi , ϕi , z ij )f (zz j |x3j , τ0 , τ1 )dzz j f (x3j |µ3 , ϕ3 ),

i=1

(2.7)
where x1j and x2j are from observed data and z j = (z1j , z2j )′ . x1j and x2j are
independent given z j . Hence, the posterior joint distribution of µ1 , µ2 , µ3 , ϕ1 , ϕ2 , ϕ3 ,
τ0 , τ1 given the observations is proportional to
Y
n Z Y
2
j=1





f (xij |µi , ϕi , z ij )f (zz j |x3j , τ0 , τ1 )dzz j f (x3j |µ3 , ϕ3 ) π (θθ ),

i=1

where f (xij |µi , ϕi , z ij ) is the distribution of xij for i = 1, 2:



I

xij ∼ 


with probability pi ;

0,

P oisson[F −1

1/ϕi {Φ(zij )}µi ],

with probability 1 − pi .

The dropout rate pi is study-specific and can be determined using all genes measured
in the study as a function of µi described previously. And f (zz j |x3j , τ0 , τ1 ) is the probability density function of a bivariate normal distribution with a covariance matrix
structure:






Σ=


1
e(τ0 +τ1 ×x3j ) −1
e(τ0 +τ1 ×x3j ) +1

e(τ0 +τ1 ×x3j ) −1

e(τ0 +τ1 ×x3j ) +1 

1

.

For any given x3j , z j can be derived as described in (2.4) and (2.5). Finally, f (x3j |µ3 , ϕ3 )
is formulated as in (2.1).
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For a given gene triplet, the parameter estimation can be carried out using the
MCMC algorithm provided in JAGS (Plummer, 2003). We use the normal distribution with mean 0 and variance 4/N as the priors of τ0 and τ1 , where N is the sample
1+ρ
)
size. This is because the approximate variance of Fisher’s Z-transformation log( 1−ρ

is

4
.
N −3

The priors for µ1 , µ2 , and µ3 are standard log-normal distributions. The

non-informative priors for the dispersion parameters 1/ϕ1 , 1/ϕ2 , and 1/ϕ3 are the
Gamma distribution with mean 100 and relatively large variance 10,000.
The sampling scheme during each MCMC iteration is as follows. For j = 1, 2, ..., n,
i = 1, 2, 3, we sample µi from f (µi |· ) ∝ f (µi )
f (1/ϕi |· ) ∝ f (1/ϕi )

Qn

j=1

function of
xij ∼

Qn

j=1

f (xij |µi , ϕi ) and sample ϕi from

f (xij |µi , ϕi ), where f (xij |µi , ϕi ) is the probability density



I

with probability pi ;



N B(µi , ϕi ),

with probability 1 − pi .

0,

Then we sample τ0 from
f (τ0 |· ) ∝ f (τ0 )

Qn

f (zj |τ0 , τ1 , x3j ),

f (τ1 |· ) ∝ f (τ1 )

Qn

f (zj |τ0 , τ1 , x3j ),

j=1

and sample τ1 from
j=1

  



1
0 
,
where f (zj |τ0 , τ1 , x3j ) = N2 
   (τ0 +τ1 ×x3j )
e
−1
0
e(τ0 +τ1 ×x3j ) +1
In addition, zij can be sampled from


e(τ0 +τ1 ×x3j ) −1 

e(τ0 +τ1 ×x3j ) +1 

1

.



f (zij |· ) ∝ f (xij |zij , µi , αi )f (zij |zkj ), i, k = 1, 2; i ̸= k,
where f (zij |zkj ) = N (ρj zkj , (1 − ρj 2 )).
2.2.2

Search strategies

There are several ways to implement the ZENCO approach in a genomic study. We
describe a few here: (i) for a given pair of genes (X1 , X2 ), screen the whole-genome to
11

identify the coordinator genes (X3 ) that regulate the correlation between X1 and X2 ,
or (ii) for a given X3 , screen-related pathways or the whole-genome to identify pairs
of genes that are modulated by X3 (m choose 2 gene pairs; m is the total number of
genes considered), or (iii) if no prior information about X3 or (X1 , X2 ) is available,
screen relevant genetic pathways, or screen the whole-genome to identify potential
gene triplets that exhibit dynamic correlation changes (m choose 3 gene triplets). In
the experimental data analysis described in Section 4, we demonstrated the second
(ii) approach.
When the number of relevant genes under consideration is large (for example
≈ 20,000), a pre-screening step is usually beneficial before implementing ZENCO.
For example, the algorithm proposed by Gunderson and Ho (2014) or the screening
statistic (ζ) introduced in Yu (2018) or filtering out gene with constant expression
has been used effectively in the literature.

2.3

Simulation

To evaluate the performance of our proposed ZENCO model and compare it to existing benchmark approaches, we report results from five simulation scenarios below.

2.3.1

Scenario 1: Simulating data from ZENCO

In this first simulation, we demonstrate generating data from the ZENCO model.
The simulated data contain count-based expression level of three genes: X1 , X2 , and
X3 . In our model, the correlations of X1 and X2 are modulated by the level of X3 .
This simulation was conducted as follows.
First, we simulated a set of {x3j }N
j=1 from a univariate negative binomial distribution with mean µ3 and size ϕ3 and then randomly selected a subset as the dropouts
and replaced these {x3j }′ s with zero. After the simulation of x3j , we calculated correlation coefficient ρj =

e(τ0 +τ1 ×x3j ) −1
e(τ0 +τ1 ×x3j ) +1

for each x3j . Note that for dropouts in {x3j }N
j=1 ,
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we used µ3 instead of x3j to calculate ρj , since the values of those dropouts have
nothing to do with the regulatory mechanism
we generated latent vari
 X3 . Then,
  of

 0
   1 ρj 
′




ables zj = (z1j , z2j ) such that zj ∼ N2   , 
 and simulated x1j and x2j
ρj 1
0
using zj as described in (2.6). The dependence structure of x1j and x2j is implicitly
modeled via zj . Finally, just like the simulation of x3j , we randomly replaced values
of x1j and x2j for dropout events.
Using the simulation approach described above, we generated 105 observations
from the ZENCO distribution and plotted a panel of conditional distributions of X1
and X2 given various levels of X3 in Figure 2.1. In these figures, we observed that
when X3 is not zero, ρ increases with X3 . When X3 is zero, the correlations of X1
and X2 are small and show reduced dependency with respect to X3 . This is due to
the zero value observation of X3 being a mixture of true zero and dropout. In other
words, some zero values of X3 come from the negative binomial distribution, others
come from dropout events.

2.3.2

Scenario 2: Comparisons to existing approaches

To evaluate the performance of our proposed ZENCO model, we performed power
analysis and compare ZENCO to three other existing approaches. For testing the
existence of dynamic co-expression changes, our hypotheses are set up as:
H0 : τ1 = 0 versus H1 : τ1 ̸= 0.
First, we compared ZENCO to a bivariate negative binomial regression without considering the zero-inflated components. Similarly to ZENCO, the statistical power
of this method can be calculated as the percentage of times that the posterior 95%
credible intervals of τ1 do not cover zero. The ZENCO model and the model without
considering the zero-inflated components were both carried out using the MCMC al13

Figure 2.1. Profile plots of (X1 , X2 |X3 ) with varying X3 ( µ1 = µ2 = µ3 = 15,
ϕ1 = ϕ2 = ϕ3 = 4, τ0 = 0, and τ1 = 0.05)
gorithm with 20,000 iterations, and 10,000 burn-ins.
Second, we compared ZENCO to the existing benchmark approach introduced
by Li (2002). This existing approach was later applied to scRNA-seq data by Yu
(2018). This test statistic according to the three-product-moment measure is written
as: TLA =

b ∗1 X∗2 X∗3 )
E(X
b ∗1 X∗2 X∗3 )}
SE{E(X

, where X∗1 , X∗2 , X∗3 are the standardized X1 , X2 , X3 with

∗ ∗ ∗
b
mean 0, variance 1, and E(X
1 X2 X3 ) is the three-product-moment estimator for the
∗ ∗ ∗
∗ ∗ ∗
b
b
dynamic correlation. SE{E(X
1 X2 X3 )}, the standard error of E(X1 X2 X3 ), can be

estimated via bootstrap. TLA can be used to test whether the correlation of X1 , X2
depends on X3 , that is H0 : τ1 = 0 (Li, 2002; Ho et al., 2011). The distribution of TLA
under the null hypothesis and associated p-value can be obtained using a permutation
approach.
The third comparison is to fit the negative binomial count data with the conditional normal model (CNM-Full) (Ho et al., 2011). Assuming data are from the
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conditional bivariate normal distribution instead of the conditional bivariate negative binomial distribution, the test statistic of this method can be estimated using a
generalized estimating equation-based procedure (Yan and Fine, 2004) and a p-value
associated with the test statistic can be obtained. The powers of these two methods
(TLA and CNM-Full) can be calculated by counting the percentage of times when
p-values associated with τ1 are less than 0.05.
We simulated 1,000 observations from ZENCO model by fixing µ1 = µ2 = µ3 = 15,
ϕ1 = ϕ2 = ϕ3 = 4 and τ0 = 0, and then varied τ1 values and performed power analyses.
The simulated values of µ1 , µ2 , µ3 , ϕ1 , ϕ2 , ϕ3 are based on the estimates obtained from
the real data analysis. Figure 2.2 shows the power curves of the four methods. We
observed that our proposed ZENCO method outperforms the other three methods. In
addition, fitting the negative binomial count-based data using Gaussian-based models
reduces statistical power drastically. This is because ZENCO accounts for both zeroinflation and overdispersion of the data, and hence achieves better power to detect
dynamic dependence structure.

2.3.3

Scenario 3: Estimation efficiency

In this simulation scenario, we evaluated the estimation efficiency of the ZENCO
model and reported mean squared errors (MSE), mean bias errors (MBE), and 95%
empirical coverage probabilities under various settings. Three sets of simulation studies were done with sample sizes 200, 500, and 1,000. For each simulation study, we
generated 1,000 datasets. We used the parameter estimated values obtained from the
real data analysis in Section 4 and set the true values of the parameters as follows:
µ1 = µ2 = µ3 = 15, ϕ1 = ϕ2 = ϕ3 = 4, τ0 = 0.01, and τ1 = 0.05. The true values
of the parameters associated with dropout rate were similar to the values obtained
based on the real data: b0 = 0.14 and b1 = −0.02 (dropout rates for X1 and X2 are
both 0.44).
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Figure 2.2. Power curves comparing various methods. Both TLA and CNM-Full
approaches are Gaussian-based models.
The empirical 95% coverage probabilities from the posterior distributions and the
length of credible intervals are shown in Table 2.1. In Table 2.1, we also presented
the parameter estimates using a negative binomial model without zero-inflation. The
empirical 95% coverage probability is calculated as the percentage of times when
the 95% credible intervals covering the true parameter value based on 1,000 MCMC
simulations. The simulation results shown in Table 2.1 suggest that ZENCO model
provides a much better 95% coverage probability than a negative binomial regression
method model without zero-inflation.
MSEs and MBEs are shown in Table 2.2. The MBE of a given parameter β is
calculated as

1
N

PN

i=1 (βi

b

− β); N is the number of simulation iterations (N=1,000).

Based on the simulation results in Table 2.2, ZENCO model has smaller MSEs and
MBEs comparing with the non-zero-inflated negative binomial regression method.
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Table 2.1. Coverage probability of 95% credible intervals (CIs) and interval lengths
based on 1,000 MCMC simulations (τ0 = 0.01, τ1 = 0.05)
Parameter
τ0
N = 200
τ1
τ0
N = 500
τ1
τ0
N = 1, 000
τ1

Without Zero-inflation
Coverage probability CI length
1.000
0.237
0.154
0.041
1.000
0.223
0.006
0.022
0.957
0.205
0.000
0.015

With Zero-inflation
Coverage probability CI length
1.000
0.246
0.957
0.095
1.000
0.244
0.961
0.059
1.000
0.242
0.954
0.040

Table 2.2. Mean square errors (MSE) and mean bias errors (MBE) based on 1,000
MCMC simulations (τ0 = 0.01, τ1 = 0.05)

N = 200
N = 500
N = 1, 000

2.3.4

Without Zero-inflation
Parameter MSE
MBE
τ0
0.001
0.005
τ1
0.002
-0.039
τ0
0.002
0.024
τ1
0.002
-0.040
τ0
0.004
0.048
τ1
0.002
-0.041

With Zero-inflation
MSE
MBE
0.000
-0.008
0.001
-0.006
0.000
-0.009
0.000
-0.001
0.000
-0.009
0.000
0.000

Scenario 4: Robustness

In order to assess the robustness of the ZENCO method under model misspecification,
we conducted three sets of simulations where the data are generated via a negative
binomial model without zero-inflation. The three sets of simulation studies were
performed with sample sizes 200, 500, and 1,000, and each with 1,000 simulation
iterations. The true values of parameters were set as µ1 = µ2 = µ3 = 15, ϕ1 =
ϕ2 = ϕ3 = 4, τ0 = 0.01, and τ1 = 0.05. We analyzed the simulated datasets using a
negative binomial regression method without zero-inflation and the ZENCO method.
The empirical 95% coverage probabilities from posterior distributions and the
length of credible intervals using the above two models are shown in Table 2.3; the
MSEs and MBEs are shown in Table 2.4. The results shown in Table 2.3 and Table
2.4 suggest that our proposed estimation procedure in ZENCO is fairly robust even
when the data are generated from a non-zero-inflated negative binomial setting.
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Table 2.3. Coverage probability of 95% credible intervals (CIs) and interval lengths
for τ0 and τ1 estimates based on 1,000 MCMC simulations with non-zero inflated data
(τ0 = 0.01, τ1 = 0.05)
Parameter
τ0
N = 200
τ1
τ0
N = 500
τ1
τ0
N = 1, 000
τ1

Without Zero-inflation
Coverage probability CI length
1.000
0.235
0.951
0.034
1.000
0.220
0.957
0.021
0.999
0.200
0.953
0.015

With Zero-inflation
Coverage probability CI length
1.000
0.238
0.957
0.037
1.000
0.223
0.949
0.022
0.999
0.203
0.958
0.016

Table 2.4. Mean square errors (MSE) and mean bias errors (MBE) based on 1,000
MCMC simulations with non-zero inflated data (τ0 = 0.01, τ1 = 0.05)

N = 200
N = 500
N = 1, 000

2.3.5

Parameter
τ0
τ1
τ0
τ1
τ0
τ1

Without Zero-inflation
MSE
MBE
0.000
-0.009
0.000
0.000
0.001
-0.009
0.000
0.000
0.001
-0.008
0.000
0.000

With Zero-inflation
MSE
MBE
0.000
-0.010
0.000
0.002
0.001
-0.009
0.000
0.001
0.001
-0.008
0.000
0.001

Scenario 5: A multiple-gene setting

In this simulation scenario, we turn our attention to a multiple-gene setting. Our
goal here is to demonstrate our proposed approach could capture dependencies among
multiple genes through multiple pairwise searches. We set b0 = 0.65 and b1 = −0.015,
which is similar to the values obtained based on the real data and then simulated 5
genes (10 gene pair combinations) with µ1 = 15, µ2 = 19, µ3 = 10, µ4 = 15, µ5 = 12,
ϕ1 = 4, ϕ2 = 5, ϕ3 = 6, ϕ4 = 4, ϕ5 = 3. The true values of the 10 τ1′ s range from
0.005 to 0.05, while the true value of τ0 was set as 0. The empirical 95% coverage
probabilities and MBEs of 10 τ1′ s are shown in Table 2.5. The results indicate that
our method demonstrated desirable performance under a multiple-gene setting.
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Table 2.5. Coverage probability of 95% credible interval and MSEs for τ1 estimates
based on 1,000 MCMC simulations for 5 genes (10 gene pairs)
Pair
(G1 , G2 )
(G1 , G3 )
(G1 , G4 )
(G1 , G5 )
(G2 , G3 )
(G2 , G4 )
(G2 , G5 )
(G3 , G4 )
(G3 , G5 )
(G4 , G5 )
2.4

τ1
0.0050
0.0100
0.0150
0.0200
0.0250
0.0300
0.0350
0.0400
0.0450
0.0500

τb1
0.0054
0.0091
0.0128
0.0161
0.0211
0.0256
0.0292
0.0344
0.0385
0.0435

MSE Coverage probability
0.0003
0.952
0.0004
0.962
0.0003
0.971
0.0004
0.960
0.0004
0.964
0.0004
0.952
0.0004
0.930
0.0004
0.949
0.0005
0.941
0.0004
0.949

Experimental Data Analysis

We used the proposed ZENCO model to analyze the melanoma data set described
in Rambow et al. (2018). The scRNA-seq data were obtained from Gene Expression
Omnibus (GEO accession number: GSE116237). The data set consists of 57,445
genes and 674 melanoma cells. To study minimal residual disease (MRD) as well
as relapse during melanoma treatment, Rambow et al. (2018) performed single-cell
RNA sequencing using malignant cells from BRAF-mutant patient-derived xenograft
melanoma cohorts treated with BRAF/MEK inhibitor (dabrafenib/trametinib).
During the course of continuous treatment with BRAF/MEK inhibitor, the transition of tumor cells can be categorized into three phases: phase 1 is in the early
stage when all treated lesions rapidly shrunk upon initial treatment (BRAF-inhibitor
sensitive); phase 2 is the second stage when drug-tolerant tumor cells remain viable
upon continuous treatment (MRD); in phase 3, relapse is observed and tumor cells exhibit adaptive resistance to continuous BRAF inhibition treatment (BRAF-inhibitor
resistance). Among the 674 melanoma cells in the data set, there are 155 phase 1
cells, 199 phase 2 cells, and 148 phase 3 cells. More details can be found in Rambow
et al. (2018).
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To gain insight into transcriptional switches of genetic circuits in tumor cells
during the course of BRAF-inhibitor treatment, we set out to identify gene pairs that
interact with BRAF differently between BRAF-inhibitor sensitive cells (phase 1) and
BRAF-inhibitor resistance cells (phase 3). Hence in this analysis, we chose BRAF as
X3 and conducted the pairwise analysis for genes in the melanoma pathway described
in the KEGG database (Kanehisa and Goto, 2000). According to the melanoma
pathway in KEGG database, 72 genes were identified as melanoma-associated genes.
The data were first preprocessed by the procedures described in McCarthy et al.
(2017). After removing low expressed genes (maximum count across all cells less
than 5) and genes with more than 70% zeros in either phase 1 cells or phase 3 cells,
28 genes were selected for further analysis.
The study-specific parameters, b0 , b1 , associated with dropout rates can be estimated using the logistic function p =

e(b0 +b1 µ)
.
1+e(b0 +b1 µ)

In the logistic function, we used

the sample mean to estimate µ. After calculating the dropout rate as the proportion
of cells with zero counts, a non-linear least-squares approach was then applied to
calculate b0 and b1 .
We implemented ZENCO analyses for 351 gene pair combinations in phase 1 cells
and phase 3 cells and obtained the estimates of τ1 . To identify the gene pairs that
interact with BRAF differently, we chose gene pairs that are in both phase 1 and
phase 3 cells and calculated the differences of τ1 estimates between the two phases.
The top 30 gene pairs with the largest differences of τ1 between phase 3 and phase
1 are shown in Table 2.6. The first two columns in Table 2.6 are the names of two
genes. τ1 (P 1) is the estimated τ1 in phase 1 cells, and τ1 (P 3) is the estimated τ1 in
phase 3 cells. ∆τ1 is defined as τ1 (P 3) − τ1 (P 1). It quantifies the change of dynamic
co-expression in relation to BRAF between phase 3 and phase 1 cells.
From Table 2.6, we observed that genes PDGFC and FGFR1 have the largest |∆τ1 |
between phase 1 and phase 3 cells. In phase 1 cells, the estimate of τ1 for PDGFC
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and FGFR1 is 0.045 and the 95% credible interval does not contain 0. In phase 3
cells, the estimate of τ1 is close to 0. This suggests that the regulatory mechanism
between BRAF and the gene pair (PDGFC, FGFR1) changes between phase 1 and
phase 3 cells. Czyz (2019) pointed out that melanoma cells somehow acquire the
ability to grow independent of the two growth factors: FGFR1, PDGFC which helps
melanoma cells to gain resistance toward BRAF treatment. Our finding from Table
2.6 is consistent with this finding. Interestingly, many top gene pairs listed in Table
2.6 are from the mitogen-activated protein kinase (MAPK) and phosphoinositide
3-kinase (PI3K) signaling pathways. Our analysis findings support the hypotheses
described in Villanueva et al. (2011).
In the above analysis, the convergence of MCMC was assessed using the GelmanRubin convergence statistic (Gelman et al., 1992). The convergence statistics were
close to 1 for all τ1 estimates in all 351 gene pairs. The trace plots of the top 5 gene
pairs are shown in Figure 2.3. In our real data application, it took 67 minutes to
implement ZENCO with 3 chains (100,000 iterations each) for all 351 gene combinations using 13 computing cluster nodes (each with 28 2.4 GHz Intel Xeon E5-2680 v4
processors).

2.5

Discussion

In this chapter, we presented a zero-inflated negative binomial dynamic correlation
model for studying covariate-dependent correlations in zero-inflated, over-dispersed
count data, such as scRNA-seq data. In our model, the correlation of two genes is
regulated by the expression level of the third gene; a phenomenon we named dynamic
correlation in this chapter. This novel dynamic correlation focuses on studying the
changes of conditional correlation. It is a different measure from the partial correlation coefficient. The partial correlation quantifies the amount of residual correlation
between X1 and X2 after regression on X3 to adjust for the influence of X3 (Li, 2002).
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Figure 2.3. Trace plots of the top 5 gene pairs reported in the experimental data
analysis
The proposed model in this chapter takes both over-dispersion and zero-inflation
of the data into consideration. With the proper choice of the values of parameters
τ0 and τ1 , the relationship between conditional correlation and the expression level
of the third gene can be positive or negative. As demonstrated by our simulation
studies, the ZENCO model significantly outperforms other existing approaches.
Two other prior distributions for the dispersion parameters ϕ1 , ϕ2 , and ϕ3 have
been implemented: an informative Gamma distribution on ϕ1 and a half-t distribution
√
on ϕ. Our sensitivity analysis suggests that the ϕ1 , ϕ2 and, ϕ3 estimates are robust
regardless of prior distribution assumptions. The Gamma distribution with mean
100 and relatively large variance 10,000 used in this chapter is more general and has
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slightly better performance in MCMC parameter estimates.Moreover, in our model, ρ
is the correlation of the latent variable Z. The Fisher transformation of ρ is assumed
1+ρ
to be linear with X3 . In a more general setting, the relationship between log( 1−ρ
)

and X3 does not have to be linear. And our model can be easily adapted to other
functional forms.
In the melanoma data analysis, X3 was used to denote the expression level of
BRAF. And ZENCO model was implemented for each pairwise combination of X1
and X2 in the KEGG melanoma pathway. Using this search strategy, we found
the pairs of genes whose BRAF-associated dynamic correlations change significantly
between different phases during treatment. In Table 2.6, we reported the top genes
with the largest |∆τ1 |. Several existing type I error control approaches can be used
in conjunction with the Bayesian model framework in ZENCO such as Käll et al.
(2008); Dawson and Kendziorski (2012). As described in Section 2, there are several
ways to implement ZENCO in a genomic study. If a pre-filtering step is used before
implementing ZENCO, considerations described in Dawson and Kendziorski (2012);
van Iterson et al. (2010) could be helpful to maintain type I error control.
Furthermore, in our application, X3 was used to denote the gene expression level
of the BRAF gene because of its pivotal role in melanoma treatment and relapse in
the study. In practice, the X3 can be easily modified to represent the activity level of
a biological process or different cell types, or various cellular conditions such as tumor
status, survival probability, degree of inflammation, metastasis potential,...etc. Also,
X3 can be easily extended to represent a linear combination of several covariates or
biological processes to accommodate the complexity of biological systems in other
applications.
Because several existing procedures are available for pre-processing scRNA-seq
data to remove low-magnitude background noise, in the ZENCO model, the dropout
component is modeled as a degenerate distribution with a point mass at zero. How-
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ever, the method can be easily adapted to allow a low-magnitude Poisson distribution
to model the background noise in the dropout component.
In this chapter, our focus is on the changes in co-expression patterns between
a gene pair. It is plausible that there might exist higher-order interactions between
genes (more than two genes), a generalization of our approach to higher dimensions is
feasible. However, special treatments need to be considered to guarantee the positive
definiteness of the variance-covariance matrix in higher-dimension.
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Table 2.6. Top table of dynamic correlations differences. ∆τ1 is the difference
between τ1 estimates in Phase 3 (P3) and Phase 1 (P1).
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Gene1
PDGFC
AKT1
AKT1
PDGFC
IGF1R
MDM2
AKT1
AKT1
AKT1
KRAS
IGF1R
PTEN
PTEN
BAX
KRAS
ARAF
AKT1
NRAS
PIK3R1
IGF1R
BAK1
AKT3
PTEN
BAD
IGF1R
RB1
AKT2
BAD
NRAS
AKT2

Gene2
FGFR1
BAX
PIK3R1
MAP2K2
FGFR1
CCND1
ARAF
MAP2K1
MAPK1
PDGFC
MAP2K2
PDGFC
PIK3R1
POLK
NRAS
RB1
RAF1
MAPK1
MDM2
TP53
POLK
MAP2K2
KRAS
RAF1
CDK6
CCND1
FGFR1
TP53
BAK1
BAK1

0.045
0.040
-0.016
0.016
-0.024
0.021
-0.025
0.025
-0.003
0.012
0.025
-0.022
0.031
0.025
0.017
0.020
-0.016
0.017
0.020
-0.016
-0.018
0.016
-0.005
-0.016
0.014
0.011
-0.003
-0.001
0.001
-0.004

τ1 (P 1)
( 0.021, 0.068)
( 0.008, 0.071)
(-0.035, 0.004)
(-0.002, 0.032)
(-0.048, 0.000)
( 0.007, 0.031)
(-0.047, 0.002)
( 0.004, 0.057)
(-0.012, 0.006)
(-0.005, 0.024)
( 0.002, 0.056)
(-0.036,-0.004)
( 0.007, 0.050)
( 0.006, 0.048)
(-0.003, 0.034)
( 0.008, 0.032)
(-0.033,-0.003)
( 0.002, 0.029)
( 0.004, 0.035)
(-0.034, 0.002)
(-0.030,-0.006)
( 0.005, 0.025)
(-0.016, 0.011)
(-0.031,-0.006)
(-0.001, 0.026)
( 0.000, 0.020)
(-0.015, 0.006)
(-0.010, 0.007)
(-0.008, 0.008)
(-0.013, 0.005)
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-0.003
-0.003
0.024
-0.023
0.007
-0.011
0.007
-0.006
0.026
-0.017
-0.004
0.007
0.005
0.000
-0.008
-0.004
0.007
-0.005
-0.001
0.005
0.002
-0.003
0.012
0.000
-0.002
-0.004
0.011
0.013
0.014
0.010

τ1 (P 3)
(-0.010, 0.005)
(-0.014, 0.008)
( 0.009, 0.038)
(-0.036,-0.006)
( 0.000, 0.014)
(-0.018,-0.004)
(-0.007, 0.018)
(-0.017, 0.009)
( 0.007, 0.055)
(-0.042, 0.005)
(-0.011, 0.006)
(-0.003, 0.014)
(-0.006, 0.014)
(-0.012, 0.010)
(-0.015, 0.002)
(-0.009, 0.002)
(-0.004, 0.017)
(-0.013, 0.006)
(-0.010, 0.008)
(-0.003, 0.011)
(-0.006, 0.010)
(-0.011, 0.007)
( 0.003, 0.020)
(-0.009, 0.008)
(-0.008, 0.003)
(-0.010, 0.004)
( 0.004, 0.017)
( 0.002, 0.021)
( 0.006, 0.022)
( 0.000, 0.019)

-0.047
-0.043
0.040
-0.039
0.032
-0.031
0.031
-0.030
0.029
-0.029
-0.028
0.028
-0.027
-0.026
-0.024
-0.024
0.023
-0.021
-0.021
0.020
0.020
-0.018
0.017
0.016
-0.016
-0.014
0.014
0.014
0.014
0.014

∆τ1
(-0.072,-0.023)
(-0.075,-0.010)
( 0.015, 0.062)
(-0.059,-0.013)
( 0.006, 0.056)
(-0.044,-0.017)
( 0.002, 0.056)
(-0.063,-0.006)
( 0.007, 0.058)
(-0.057,-0.002)
(-0.060,-0.004)
( 0.008, 0.044)
(-0.048,-0.002)
(-0.051,-0.003)
(-0.043,-0.003)
(-0.037,-0.011)
( 0.006, 0.042)
(-0.037,-0.004)
(-0.038,-0.002)
( 0.002, 0.039)
( 0.006, 0.034)
(-0.030,-0.006)
( 0.000, 0.030)
( 0.002, 0.032)
(-0.029,-0.001)
(-0.025,-0.002)
( 0.002, 0.027)
( 0.001, 0.026)
( 0.002, 0.025)
( 0.001, 0.026)

Chapter 3
Clustering using gene co-expression latent
factors
3.1

Introduction

Biological molecules in a cell often participate in complicated interaction processes.
Due to the complex regulatory mechanisms, genes are often tightly regulated (de la
Fuente, 2010b). To understand the roles of genes, both the average expression levels of
genes and interactions between genes are needed to be taken into consideration. Genetic interactions analysis can be used to associate genes with biological processes or
to discern gene regulatory mechanisms (Van Dam et al., 2018). With recent advances
in next-generation sequencing, researchers are now able to study genetic interactions
systematically. In addition, interactions between genes are often highly dynamic under different cell types or cellular conditions such as tumor status (Luscombe et al.,
2004; de Lichtenberg et al., 2005). Changes in gene interactions can often result in
changes in co-expression patterns between genes. Therefore, differential co-expression
analysis can be used to identify sets of genes whose expressions change in a coordinated fashion across different cell types.
The studies of how genes interact in a cell are important when clustering cell types,
since genes in different cell types could interact differently. Clustering has been the
routine of single-cell data analysis and cell-type identifying. The single-cell RNA
sequencing technologies have made it possible to discover the groupings of a set of
cells on the basis of transcriptome similarity. Diverse types of clustering approaches
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have been developed. For example, the two widely-used clustering algorithms are kmeans clustering and hierarchical clustering. However, both k-means and hierarchical
clustering have their own limitations when it comes to high-dimensional data sets
(Kiselev et al., 2019). Therefore, graph-based clustering approaches are becoming
more and more popular in scRNA-seq data and have been incorporated into some
user-friendly packages such as Seurat (Stuart et al., 2019) and scanpy (Wolf et al.,
2018).
Although great progress has been made in terms of clustering approaches, the
effects of the genetic interactions have not been taken into consideration. The traditional clustering approaches use average expression levels of the data and are therefore
insufficient for understanding the intricate regulatory mechanisms that underlie different cellular conditions. The co-expression structures can often bring insights into
the complex genetic interactions (Yu, 2018) and can help detect correlation changes
between pairs of genes across different modulating conditions. Therefore, the coexpression structures can help identify hidden sub-groups in the data and improve
the performance of clustering.
Latent pathway activities can affect both the average expression levels of genes
and the co-expression levels between genes. Therefore, both expression levels and
co-expression levels contain a part of the latent pathway activities information. Some
pathway activities may only affect the average expression levels of genes, some may
only affect the co-expression levels between genes, and some may affect both. Dimensionality reduction approaches such as JIVE (Lock et al., 2013) and MSFA (De Vito
et al., 2019) consider the mixed factors and can be used to decompose the data (Cantini et al., 2021). The ability of the dimensionality reduction approaches to separately
estimate the joint structure and source-specific structures can contribute significantly
to the interpretation of the latent pathway activities. We consider both the expression structures and co-expression structures of the data to find the latent pathway
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activities in different sources. We then use the latent factors to conduct cell-type
clustering.
In this chapter, we propose a cell-type clustering approach that allows for joint
analysis of both expression structures and co-expression structures of the data. Our
method learns the joint features shared among data sources and identifies the unique
variation present in each source to further cluster the cell types. The remainder of
the chapter is arranged as follows. In Section 3.2, the detail of the proposed model
is introduced. The simulation studies and comparisons are conducted in Section 3.3.
In Section 3.4, the analysis of scRNA-seq data generated from breast cancer cells is
presented.

3.2

Method

We consider two matrices in the model: original matrix X and product matrix Xprod .
Xprod is the differential co-expression patterns calculated from X. Each matrix has
n columns representing n cells in gene expression data. X is a p1 × n matrix, and
Xprod is a p2 × n matrix. In our method, we treat them as two data sources. The
original matrix X = (X1 , ..., Xp1 )T is the matrix of gene expression data. Xi is the
vector of the expressions of the ith gene. Without loss of generality, we normalized
the data with mean 0 and variance 1 for every gene. Hence, the correlation of the ith
gene and the jth gene
Corr(Xi , Xj ) = E(Xi Xj ).

(3.1)

The product of gene pairs Xi and Xj estimates correlation and captures the interaction between these two genes. Since the number of genes in Xp1 ×n is p1 , there will be
p′ =

 
p1
2

gene pairs in total. We can construct a new matrix Wp′ ×n = (W1 , ..., Wp′ )T

with

 

rows and n columns. Each row of Wp′ ×n is equal to the entry-wise product

p1
2

of Xi and Xj , ∀ i ̸= j. Usually, the number of genes p1 in the gene expression data is
over 104 . In this situation, there are around 108 different gene pairs. Therefore, we
28

need to prescreen the gene pairs and only keep the gene pairs that are informative
on the cellular states. In other words, we need to find the gene pairs that are likely
to have dynamic co-expression patterns in different types of cells in the data. The
difficulty is that the cell types of the data are unknown. Yu (2018) solves this problem using a new metric, called Liquid Association Coefficient (LAC) score without
knowing the cellular states or sub-classes in advance. The LAC score is defined as
LACij = r(|Xi |, |Xj |) − |r(Xi , Xj )|,

(3.2)

where r() is the Pearson correlation coefficient. It has been shown that gene pairs
with higher LAC scores are more likely to have dynamic correlation patterns. We
then use LAC scores for all gene pairs to find the top p2 potential dynamic correlated
gene pairs and store them in the new matrix Xprod .
The latent pathway activities can affect both the original matrix X and the product matrix Xprod . Therefore, factor analysis is needed to find the factors associated
with the latent processes. In addition, considering the high dimensionality of X and
Xprod , feature selection or dimension reduction are needed to speed up calculations.
Traditional approaches only perform dimension reduction on original matrix X, while
our model uses both expression matrix X and co-expression matrix Xprod . Since the
size and the scale of X and Xprod often differ, we center and scale both matrices to
have a mean 0 and a variance of 1 within each row. The model can be defined as
follows:
X = J1 + I1 + U1

(3.3)

Xprod = J2 + I2 + U2
Let I1 be the matrix representing the individual structure of X, and let I2 be
the matrix representing the individual structure of Xprod . J1 and J2 represent the
joint factor matrices of X and Xprod . U1 and U2 are the matrices of residuals. In
a factorized model, for i = 1, 2, the joint structure Ji can be written as Wi F. The
individual structure matrix Ii can be written as Bi Fi . Therefore, the model can be
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written as:
X = W1 F + B1 F1 + U1

(3.4)

Xprod = W2 F + B2 F2 + U2
The joint structure is represented by the common factor matrix F. The loading matrices Wi indicate how these joint factors are expressed in the rows of the corresponding
matrix. Individual structure Ii is represented by the factor matrix Fi with variable
loading matrix Bi . The original matrix X comprises joint structure W1 F, individual
structure B1 F1 , and residual U1 . Both the joint and individual structure of X can
be obtained using traditional dimension reduction. The joint structure W2 F cannot
provide any additional information than W1 F, because they share the same factor
matrix F. Therefore, the individual structure B2 F2 is the additional information
provided by product matrix Xprod .
The joint structure and individual structure between the original matrix and product matrix in the above model can be found by Joint and Individual Variation Explained (JIVE) (Lock et al., 2013). JIVE is a decomposition of data as the sum of
two factorizations: a low-rank matrix capturing joint features across two data sources,
and low-rank omics-specific factor matrices capturing individual features. It’s worth
noting that the matrix capturing individual features of co-expression structures contains additional information which the first-order structures can not provide. The
ranks of estimated joint and individual structures can be determined by the number
of components in PCA with the proportion of variance explained > 0.05. The ranks
can also be determined by JIVE using permutation testing. Since the individual
structure I2 = B2 F2 contains additional information provided by the product matrix, which has not been considered in the traditional clustering approaches, we can
use this additional information for further clustering. The further clustering using
I2 to find sub-classes of cell types is the same procedure as the traditional clustering
methods. Therefore, any clustering method that works well on traditional gene ex-
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pression data can be used on I2 . According to (Kiselev et al., 2019), the combination
of shared-nearest-neighbor graphs and Louvain community detection, which has been
used in packages such as Seurat and scanpy, is one of the popular choices of clustering
methods. We adapt the same methods for further clustering the cell types using I2 .

3.3

Simulation

As a basic illustration, we use three latent vectors z1 , z2 , and z3 in the simulation to
represent three sets of latent pathway activities. z1 controls the individual coexpression structure of the data, z2 controls the individual average expression structure of
the data, and z3 controls the joint structure of the data. The simulated data contains
two blocks, block 1 and block 2, with simple patterns corresponding to individual and
joint structures respectively. In each block, we simulated 400 genes with 1000 samples. In block 1, genes are simulated with z1 and z2 . In block 2, genes are simulated
with z3 . The patterns of z1 , z2 , and z3 are in Figure 3.1.
The data simulation schematic is demonstrated in Figure 3.2. The first heatmap
represents the original matrix of the data. The columns of the heatmap are samples
and the row of the heatmap are genes. The first half of original matrix is block 1,
and second half is block 2. Block 1 is from gene 1 to gene 400, and block 2 is from
gene 401 to gene 800. The second heatmap in Figure 3.2 is the ideal product matrix
we are trying to simulate. The columns of the heatmap are samples and the row of
the heatmap are gene pairs. The product matrix also have two blocks with different
patterns. Moreover, we can observe that the block 2 in original matrix and the block
2 in the product matrix share the same pattern, while block 1 in these two matrices
have different individual structures.
Specifically, to simulate block 1 of the data matrix, we first generated the latent
vector z1 corresponding to 1000 samples. In this simulation study, the first 500 samples of z1 are -1 and the remaining 500 samples are 1. We then generated a latent
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Figure 3.1. The patterns of latent vectors z1 , z2 , and z3 . Different colors represent
different values.
z2 with 1000 elements. Samples 1 to 250 and samples 501 to 750 in z2 are 1 and
the remaining samples are 2. Then, correlation ρ was calculated as

exp(τ1 ∗z1 +τ0 )−1
.
exp(τ1 ∗z1 +τ0 )+1

The 200 gene pairs (400 genes) were generated one by one through bivariate normal distribution using (z2 , z2 ) as the mean and ρ as the correlations. The random
noise generated from standard normal distribution was added to each gene. Using
the simulation setting described above, the correlations and means of genes in block
1 are respectively controlled by z1 and z2 . This represents the individual structure
between the original matrix and product matrix of block 1. To generate block 2, we
use latent vector z3 which has different pattern as z1 and z2 . Then, ρ was calculated
as

exp(τ1 ∗z3 +τ0 )−1
.
exp(τ1 ∗z3 +τ0 )+1

The 200 gene pairs were generated one by one through bivariate

normal distribution using (z3 , z3 ) as the mean and ρ as the correlations. Therefore,
genes in block 2 have joint structures for the original matrix and product matrix.
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Figure 3.2. Simulation schematic for original matrix and product matrix in simulation. Different colors represent different values.
We then implemented the proposed method to cluster the samples. We first
normalized the simulated data matrix with mean 0 and variance 1 for every gene. To
select the gene pairs that were most likely to have the dynamic correlation, we used
a pre-screening method proposed in (Yu, 2018). We computed the LAC scores for
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all possible gene pairs and stored the gene pairs with LAC scores above 0.08 in the
product matrix Xprod . Our goal is to identify both the joint structure and individual
structures of two matrices. Figure 3.3 shows the heatmaps of the original matrix and
product matrix, the JIVE estimates for joint structure, individual structures, and
random noises. The first row of Figure 3.3 represents the original matrix. We can see
that the heatmap of the original matrix is the same as the original matrix in Figure
3.2. The second row of Figure 3.3 displays the product matrix of the simulated data.
Our proposed method successfully find the individual structures and joint pattern
between these two matrices. Actually, the individual pattern of the product matrix
has the same pattern as z1 . The individual pattern of the original matrix has the
same pattern as z2 . And the joint pattern between the original matrix and product
matrix has the same pattern as z3 .
Figure 3.4 shows the UMAP plot of the original simulated data. We can see that
the four different clusters can be found using the original matrix. In fact, the original
matrix only contains the patterns of z1 and z3 . This is why the UMAP plot of it
has four clusters (z1 and z3 both have two classes). The four clusters can be further
clustered if we use the information from the product matrix. We use cluster 1 in
Figure 3.4 as an example. Cluster 1 can not be further clustered using the original
matrix. However, we can further cluster it using the individual pattern of the product
matrix. Figure 3.5 shows the sub-cluster of cluster 1. The colors in Figure 3.5 indicate
there are two different sub-clusters. It shows that cluster 1 can be further clustered
using the individual pattern of the product matrix, which is also the pattern of z2 .

3.4

Experimental Data Analysis

To demonstrate how our approach can be used to further cluster cell types, we analyzed the breast cancer data described in (Yeo et al., 2020; Fultang et al., 2021).
The scRNA-seq data were obtained from Gene Expression Omnibus (GEO accession
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Figure 3.3. Heatmaps from the JIVE output.

Figure 3.4. UMAP plot of original matrix in simulation.
number: GSE123366). The data set consists of 13,745 cells from four samples (1903
4T1 cells, 3102 BRCA1-null cells, 4173 PyMT cells, and 4567 Neu cells). In our study,
we focused on finding the sub-clusters of BRCA1-null cells. The BRCA1-null data
are from two different sample libraries. We first integrated the BRCA1-null cells from
these two sample libraries using the Seurat package in R. Before the integration, we
filtered cells that have unique feature counts over 6,000 or less than 200, normalized
the data, and selected the top 2000 high cell-to-cell variation features in each dataset.
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Figure 3.5. UMAP plot of cluster 1 only. The different colors represent different
sub-clusters of cluster 1 found using individual pattern of the product matrix.
We then used the integrated dataset of BRCA1-null cells to conduct cell types clustering. The integrated dataset contains information of the expression level of genes
or features. Traditional approaches such as the Seurat package conduct the cell-type
clustering using only the integrated dataset itself. We first used the Seurat package
to cluster the cell types of BRCA1-null cells. The UMAP plot of the clusters is in
Figure 3.6. Traditional approaches can only cluster cell types to this extent because
only the information of the original matrix is used.
To further cluster the cell types in Figure 3.6, more information are needed. We
calculated the LAC score for each gene pair in integrated data to select the highly
dynamic correlated gene pairs and generated the product matrix. The joint structure
and individual structures between the integrated dataset and its product matrix were
obtained from JIVE. In this analysis, we focused on cluster 0 in Figure 3.6, because
the number of cells in cluster 0 is larger than in other clusters. The individual
structure of the product matrix, which is the additional information provided by the
product matrix, is denoted as I2 . The UMAP plot of I2 matrix is shown in Figure
3.7. Figure 3.7 shows that I2 can be used for cell-type clustering just like the original
matrix does. We used the I2 matrix to further cluster cell types in cluster 0. Figure
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Figure 3.6. UMAP plot showing the individual clusters using original matrix.
3.8 is the UMAP plot for cluster 0 only. From Figure 3.8, we know that I2 contains
additional information that can be used to further cluster the cells in cluster 0. Using
I2 , cluster 0 can be further clustered as 7 subclusters. Among those 7 subclusters in
cluster 0, most cells are in subclusters 1, 3, 4, and 6. The heatmap of all cluster 0
cells in I2 matrix is shown in Figure 3.9. We can see that the four subclusters have
distinct patterns in the heatmap. The rows of the matrix are different gene pairs. The
heatmap shows that the co-expression patterns of gene pairs in different subclusters
are different.
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Figure 3.7. UMAP plot showing the individual clusters using I2 matrix.
3.5

Discussion

In this chapter, we presented a cell-type clustering approach that allows for joint
analysis of both expression structure and co-expression structures of the data. Compared with traditional cell-type clustering approaches which only consider average
expression structures of data, our approach can bring insight into the genetic interactions and help identify hidden sub-groups in clustering. The joint component and
two individual components from the joint analysis can reveal different types of latent
pathway activities.
Our method uses factor analysis and doesn’t require distribution assumptions.
Moreover, our method can adapt to any factor analysis approach. For instance, when
analyzing zero-inflated data, we can use zero-inflated factor analysis (Pierson and
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Figure 3.8. UMAP plot showing the subclusters of cluster 0 using I2 matrix.

Figure 3.9. Heatmap of cluster 0 cells in I2 matrix.

39

Yau, 2015). Moreover, in this paper, we use shared-nearest-neighbor graphs and
Louvain community detection for cell type clustering. Other clustering approaches
can also be used if needed. Moreover, not only hard clustering can be used in our
model, but soft clustering approaches such as fuzzy clustering, which allows data
points to belong to multiple clusters, can also be used.
Our focus in this paper is on cell-type clustering. The joint analysis of both
expression and co-expression has a lot of potential applications. This is because the
output of the joint analysis is three matrices: one joint structure and two individual
structures. We can apply the existing approaches for gene expression analysis to these
three matrices. However, transformations need to be considered to make sure the
three matrices meet the required assumptions such as normality for each expression
analysis approach.
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Chapter 4
Modeling Dynamic Correlation in Zero-inflated
Bivariate Count Data with Random Effects
4.1

Introduction

Recent single-cell RNA sequencing (scRNA-seq) studies have given insight into individual cells’ behavior and function at various stages. For the scRNA-seq data, there
are two main analytical approaches: differential expression analysis and differential
co-expression analysis. Differential expression analysis considers how the average expression levels of genes vary across different biological conditions and ignores the
regulatory mechanisms among different genes. Differential co-expression analysis,
on the other hand, takes genetic interactions into consideration and can reveal the
intricate underlying gene regulatory mechanisms.
Interactions under different cellular conditions are tightly coordinated and often
highly dynamic (Luscombe et al., 2004; de Lichtenberg et al., 2005). In response
to various external stimulants and signals, genetic interactions can change flexibly.
Therefore, changes in gene co-expression patterns can often be observed (Li, 2002; Li
and Yuan, 2004; de la Fuente, 2010a). One statistical measure that can capture these
genetic interaction changes was proposed by Li (2002). This measure, referred to
as liquid association in his paper, quantifies the relationship where the co-expression
between two genes is modulated by a third "coordinator" gene. Li’s ground-breaking
work has increased the interest in analyzing genetic interactions (Li, 2002; Li et al.,
2004; Ho et al., 2007, 2011; Wang et al., 2017; Yu, 2018).
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The existing Gaussian-based approaches work well for microarray data but may
not fit the count data such as RNA sequencing reads properly. Ma et al. (2020)
proposed three Bayesian regression approaches on bivariate count data to model the
complex dependency structures. Chapter 2 of this dissertation extended the bivariate Poisson-gamma mixture model in Ma et al. (2020) to a ZEro-inflated Negative
binomial dynamic COrrelation (ZENCO) model which accounts for both the overdispersion and zero-inflation in count data. Therefore, ZENCO can be used to capture
the genetic interaction changes in scRNA-seq data. The motivating data in ZENCO
is scRNA-seq data from a patient-derived xenograft (PDX) melanoma model (Rambow et al., 2018), so ZENCO assumes homogeneity between cells and doesn’t take
the subject-specific random effects into consideration. However, cancer scRNA-seq
datasets often contain cells from multiple individuals. Tirosh et al. (2016) observed
that expression profiles of cells from the same individual tend to cluster together even
after data preprocessing and normalization. When analyzing single tumor cells from
multiple patients, inter-tumor heterogeneity needs to be accounted for in the analysis. In this chapter, we propose a subject-specific random effects model which is an
extension of ZENCO. The proposed model incorporates between-individual random
effects to account for the variation between expression measurements of cells collected
from different participants.
The remainder of the chapter is arranged as follows. In Section 4.2, the detail of
the proposed model is introduced. The simulation studies with different scenarios are
conducted in Section 4.3. In Section 4.4, the analysis of scRNA-seq data generated
from multiple melanoma tumors is presented. Section 4.5 concludes this chapter with
some discussion.
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4.2

Methods

Suppose there are s different subjects. For kth subject, there are nk different cells.
Let Xikj represent the count-based expression level of the ith gene (i = 1, 2) in the jth
cell (j = 1, 2, ...nk ) of the kth subject (k = 1, 2, ..., s). X3kj represents a third variable
that controls the correlation between X1kj and X2kj . The marginal distribution of
Xikj (i = 1, 2) is modeled as a zero-inflated negative binomial component. The
distribution of Xikj is given by
Xikj ∼




I

with probability pi ;



N B(µik , ϕi ),

with probability 1 − pi .

0,

(4.1)

µik are random effects with hyperparameters µi and σµi ,
µik ∼ N (µi , σµi ), k = 1, 2, ..., s

(4.2)

Following the same logic as the ZENCO model, we construct our conditional
bivariate negative binomial model through a Poisson-Gamma mixture setting. For
i = 1, 2 , j = 1, 2, ..., nk and k = 1, 2, ..., s, let
Xikj ∼ P oisson(uikj µik ), uikj ∼ Gamma(αi , αi ).

(4.3)

A negative binomial distribution of N B(µik , α1i ) can be generated by integrating over
uikj . The conditional correlation between X1kj and X2kj given X3kj is from a latent
variable Zkj = (Z1kj , Z2kj ).
The correlation, ρkj , of (Z1kj , Z2kj ) is specified as
log(

1 + ρkj
) = τ0k + τ1k X3kj .
1 − ρkj

(4.4)

1+ρ

log( 1−ρkj
) is the Fisher’s Z-transformation for the correlation ρkj , τ0k and τ1k follows
kj
subject-specific random effects model with mean equal to τ0 and τ1 respectively.
τ0k ∼ N (τ0 , στ0 ), k = 1, 2...s
τ1k ∼ N (τ1 , στ1 ), k = 1, 2...s
43

(4.5)

Let
Xikj ∼ P oisson[Fα−1
{Φ(Zikj )}µik ],
i

(4.6)

where Fαi (·) is the cumulative distribution function of a Gamma(αi , αi ) distribution
with αi = 1/ϕi and Φ(·) is the cumulative distribution function of a standard normal
distribution. Fα−1
maps each point in the interval (0,1) to Gamma(αi , αi ) distribui
tion. Hence, the distribution of Fα−1
{Φ(Zikj )} is Gamma(αi , αi ). The distribution
i
of Xikj ∼ P oisson[Fα−1
{Φ(Zikj )}µik ] is then a Poisson-Gamma mixture distribution,
i
which follows the negative binomial density N B(µik , ϕi =

1
).
αi

The sampling scheme during each MCMC iteration is as follows. For j = 1, 2, ..., nk ,
i = 1, 2, and k = 1, 2, ..., s, we sample µik from
Qnk

f (µik |· ) ∝ f (µik )

j=1

f (xikj |µik , ϕi ),

where f (xikj |µik , ϕi ) is the probability density function of



I

with probability pi ;

N B(µik , ϕi ),

with probability 1 − pi .

xikj ∼ 


0,

The hyperparameters µi and σµi can be sampled from
f (µi |· ) ∝ f (µi )

Qs

k=1

f (σµi |· ) ∝ f (σµi )

Qs

f (µik |µi , σµi ),

k=1

f (µik |µi , σµi ).

We then sample ϕi from
f (1/ϕi |· ) ∝ f (1/ϕi )

Qs

k=1

Qnk

j=1

f (xikj |µik , ϕi ),

Next, we sample τ0k from
f (τ0k |· ) ∝ f (τ0k )

Qnk

j=1

and sample τ1k from
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f (zkj |τ0k , τ1k , x3kj ),

f (τ1k |· ) ∝ f (τ1k )

Qnk

j=1

f (zkj |τ0k , τ1k , x3kj ),

  

1
0 
 
where f (zkj |τ0k , τ1k , x3kj ) = N2 
  ,  (τ0k +τ1k ×x3jk )
e
−1
0
(τ0k +τ1k ×x3jk )


e

(τ

×x

+τ

)



e 0k 1k 3jk −1 

(τ +τ ×x
)
e 0k 1k 3jk +1  .

+1

1



The hyperparameters τ0 , στ0 , τ1 , and στ1 can be sampled from
f (τ0 |· ) ∝ f (τ0 )

Qs

f (τ0k |τ0 , στ0 ),

f (τ1 |· ) ∝ f (τ1 )

Qs

f (τ1k |τ1 , στ1 ),

k=1
k=1

f (στ0 |· ) ∝ f (στ0 )

Qs

f (στ0 |τ0 , στ0 ),

f (στ1 |· ) ∝ f (στ1 )

Qs

f (στ1 |τ1 , στ1 ).

k=1
k=1

In addition, zikj can be sampled from
f (zikj |· ) ∝ f (xikj |zikj , µik , αi )f (zikj |zmkj ), i, m = 1, 2; i ̸= m,
where f (zikj |zmkj ) = N (ρkj zmkj , (1 − ρkj 2 )).

4.3

Simulation

4.3.1

Scenario 1: Simulating data from proposed model

In this first simulation, we demonstrate generating data from the proposed model.
The simulated data contain count-based expression levels of genes X1 , X2 regulated
by X3 from two types of subjects. For instance, subject 1 can come from an immuneresistance tumor and subject 2 can come from an immune-sensitive tumor (JerbyArnon et al., 2018). X3 , in this case, is the immune resistance score.
Using the simulation approach described in ZENCO, we generated 105 observations from the proposed model for each subject with subject-specific τ1 and plotted a
panel of conditional distributions of X1 and X2 given various levels of X3 in Figure
4.1. In this simulation study, τ1 in subject 1 is zero, while τ1 in subject 2 is not zero.
The first row is for subject 1 and the second row is for subject 2. In these figures,
we observed that different subjects will have different correlation patterns between
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X1 and X2 when τ1 has subject-specific random effects. It’s necessary to account
for random effects for co-expression levels of gene pairs if we are interested in the
dynamic correlation changes.

Figure 4.1. Profile plots of (X1 , X2 |X3 ) with varying τ1 (τ1 = 0 vs τ1 ̸= 0)

4.3.2

Scenario 2: Estimation efficiency

To evaluate the estimation efficiency of our proposed model, we simulated 20 subjects,
each with 100 cells. The simulated data contain the level of three variables: X1 , X2 ,
and X3 , and the indicator variable for different subjects s. Therefore, the data have
2,000 rows and 4 columns. The correlations of X1 and X2 are controlled by the level
of X3 . This simulation was conducted as follows.
For each subject, a subject-specific τ0k was sampled from N (0, 0.01). Similarly,
a subject-specific τ1k was sampled from N (0, 0.0001). Different values of τ0k and τ1k
are correspond to different subjects. We then used the similar simulation strategy we
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used in Chapter 2 to simulate 100 cells for each subject. First, we simulated a set
of {x3kj }100
j=1 from a normal distribution with mean 0 and variance 1. We then calculated correlation coefficient ρkj =

(τ

+τ

×x

)

e 0k 1k 3kj −1
(τ +τ ×x
)
e 0k 1k 3kj +1

for each x3kj . The latent variables
  




0  1 ρkj 
,
 and simuzkj = (z1kj , z2kj )′ were generated such that zkj ∼ N2 
  

0
ρkj 1
lated x1kj and x2kj using zkj . For each subject, data with 100 cells were generated.


Since there are 20 subjects in total, the simulated data have 2,000 cells. The indicator
variable for different subjects was added as the fourth column of the simulated data.
We then evaluated the estimation efficiency of the proposed random effects model and
compared the random effects model with a model without considering random effects.
We reported 95% empirical coverage probabilities, mean squared errors (MSE), and
mean bias errors (MBE) in Table 4.1 and Table 4.2 for both models. We can observe
that when the data have random effects, our proposed model outperforms the model
without considering random effects. The coverage probability of 95% credible intervals in the model without subject-specific random effects is much lower than in the
proposed model. Also, the MSE and MBE are much higher in the model without
subject-specific random effects.
Table 4.1. Coverage probability of 95% credible intervals (CIs), interval lengths
based on 1,000 MCMC simulations (τ0 = 0, τ1 = 0.3, 20 subjects, 100 cells per
subject).
Parameter
µ1
µ2
ϕ1
ϕ2
τ0
τ1

Proposed model
Coverage probability CI length
0.953
2.707
0.948
2.705
0.956
0.449
0.940
0.449
0.977
0.473
0.972
0.473

47

Model without random effects
Coverage probability CI length
0.938
2.478
0.931
2.478
0.955
0.450
0.939
0.448
0.993
0.286
0.379
0.288

Table 4.2. Mean square errors (MSE), and mean bias errors (MBE) based on 1000
MCMC simulations (τ0 = 0, τ1 = 0.3, 20 subjects, 100 cells per subject).
Proposed model
Parameter MSE
MBE
µ1
0.454
-0.082
µ2
0.482
-0.027
ϕ1
0.013
0.003
ϕ2
0.013
0.000
τ0
0.012
-0.006
τ1
0.012
-0.009
4.3.3

Model without random effects
MSE
MBE
0.456
-0.102
0.479
-0.048
0.013
-0.003
0.014
-0.005
0.003
-0.001
0.029
-0.161

Scenario 3: Comparisons to existing approaches

To evaluate the performance of our proposed random effects model, we performed
power analysis and compare the model to two other existing approaches. For testing
the existence of dynamic co-expression changes, our hypotheses are set up as:
H0 : τ1 = 0 versus H1 : τ1 ̸= 0.
First, we compared the proposed model to a model without considering random
effects. The statistical power of this method can be calculated as the percentage of
times that the posterior 95% credible intervals of τ1 do not cover zero. The random
effects model and the model without random effects were both carried out using the
MCMC algorithm with 20,000 iterations, and 10,000 burn-ins.
The third method is to fit the negative binomial count data with the conditional
normal model (CNM-Full). The parameters in CNM-Full are estimated using generalized estimation equations (GEE)-based approach. The powers of CNM-Full can be
calculated by counting the percentage of times when p-values associated with τ1 are
less than 0.05.
We simulated 20 subjects each with 100 observations from the proposed model by
letting ϕ1 = ϕ2 = 2, µ1 , µ2 ∼ N (30, 1) and τ0 ∼ N (0, 0.01), and then varied τ1 values
and performed power analyses. The simulated values of µ1 , µ2 , ϕ1 , ϕ2 are based on the
estimates obtained from the real data analysis. Figure 4.2 shows the power curves of
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the three methods. We observed that both the random effects model and the CNMFull outperform the model without random effect. When τ1 is greater than 0.25, our
proposed method outperforms the other two methods. When τ1 is smaller than 0.25,
CNM-Full performs slightly better than our random effects model. This is because
Bayesian tests tend to be more conservative than the frequentist tests (Gelman and
Tuerlinckx, 2000). Also, GEE is robust to model misspecification (Hubbard et al.,
2010). However, GEE is not able to present subject-random effects. In this power
analysis, only the mean of τ1 is calculated. Oftentimes, in real data analysis, we also
need the subject-specific random effects of τ1 . In addition, Chapter 2 has shown that
when X3 has dropouts, the performance of CNM-Full will decline drastically.

Figure 4.2. Power curves comparing model without random effect and CNM-Full
model.

4.4

Experimental Data Analysis

We used the proposed model to analyze the melanoma tumor data described in JerbyArnon et al. (2018). The data were obtained from Gene Expression Omnibus (GEO
accession number: GSE115978). The data set consists of 7186 cells from 33 melanoma
49

tumors comprised of 2,987 cells from 17 newly collected patient tumors and 4,199 cells
from 16 patient tumors that Tirosh et al. (2016) previously reported. The cells were
annotated as different cell subsets such as malignant cells, CD8+ and CD4+ T cells,
B cells, natural killer (NK) cells, macrophages, cancer-associated fibroblasts (CAFs),
and endothelial cells based on expression profiles and inferred copy-number variation
(CNV) profiles. In our data analysis, we focused on malignant cells and only used
the tumors with at least 70 malignant cells.
To study the immunotherapy resistance in melanoma tumors, Jerby-Arnon et al.
(2018) identified a malignant-cell exclusion program consisting of genes induced or
repressed by malignant cells in "cold" (high-resistance to immunotherapy) versus "hot"
(low-resistance to immunotherapy) tumors. An overall expression (OE) score of gene
sets was defined in their paper to quantify the level of resistance to immunotherapy
for each cell or tumor. In our study, we scored each cell with its OE of gene set
with genes induced by malignant cells in the resistance program. The OE score was
used as X3 in this analysis. We then conducted the pairwise analysis for genes in the
melanoma pathway described in the KEGG database (Kanehisa and Goto, 2000).
To identify the gene pairs that are significantly associated with immunotherapy
resistance, we implemented the proposed model and considered tumor heterogeneity
by estimating τ1 and random effects of τ1 . For most gene pairs, the overall τ1 estimates
are not significant. This is because τ1 has subject-specific random effects. In some
tumors, τ1 estimates are significant, while in other tumors, τ1 are not significant.
Even if τ1 estimates in different tumors are all significant, the estimates can have
different signs. Therefore, it’s important and necessary to show the random effects of
τ1 . The gene pairs with significant overall τ1 estimates and standard deviation of τ1
random effects are shown in Table 4.3. Figure 4.3 shows the estimates of the random
effects for τ1 in those gene pairs. Different colors in Figure 4.3 represent different
tumors. We can see there are tumor-specific random effects of τ1 and our method
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successfully presented the random effects of τ1 . Positive τ1 means the gene pair tends
to be correlated in cold tumors, while negative τ1 means the gene pair tends to be
correlated in hot tumors. Most gene pairs in Table 4.3 and Figure 4.3 have negative
τ1 estimates, which means those gene pairs are more correlated in low-resistance to
immunotherapy tumors.
Table 4.3. Table of significant τ1 estimates and standard deviation (SD) of τ1
random effects in experimental data analysis
# Gene1
Gene2
τ1
τ1 random effects SD
1 PIK3CD KRAS -0.892(-1.856,-0.029)
0.248
2 PIK3CD BAD
-0.893(-1.804,-0.240)
0.158
3 PIK3CD CDK4
-0.904(-1.561,-0.285)
0.403
4 PIK3CD CDK6
-0.708(-1.362,-0.046)
0.105
5 AKT1
FGF5
-0.686(-1.213,-0.128)
0.120
6 KRAS
CDK4
-0.893(-1.767,-0.268)
0.306
7 CDK4
POLK -0.904(-1.727,-0.148)
0.263
8 CDK4
FGF5
-1.092(-1.714,-0.452)
0.231
9 BAK1
FGFR1 -1.792(-3.247,-0.462)
0.132
10 POLK
CDK6
-0.635(-1.380,-0.049)
0.082
11 FGF5
FGFR1 1.203( 0.072, 2.439)
0.295

4.5

Discussion

In this chapter, we presented a random effects model for studying changes of conditional correlation in scRNA-seq data with subject-specific random effects. In our
model, the correlation of two genes is regulated by the third variable. We assume the
third variable is continuous and normally distributed because the motivating data of
this study uses continuous scores as X3 .
The third variable can also be the expression level of the third gene, which means
X3 follows a zero-inflated negative binomial distribution. Although this is a different
setting that we didn’t cover in this chapter, we developed two approaches: Gaussian copula with random effects and ZENCO with random effects. The results of
simulation studies for these two approaches are provided in Appendix A.
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Figure 4.3. Random effects estimates for τ1 for gene pairs in Table 4.3. Different
color represents different tumors.
In this study, we assume the dispersion parameters ϕ1 and ϕ2 don’t have subjectspecific random effects, because the estimates from real data show ϕ1 and ϕ2 don’t
have strong random effects. This makes sense, because small changes in dispersion
parameters may lead to big changes in variance.
Our proposed model outperforms the model without considering subject-specific
random effects when the data have random effects. In practical applications, we
usually don’t know if the data have strong subject-specific random effects or not.
We can compute log-pseudo-marginal likelihood (LPML) for models with or without
random effects and do model selection based on two models’ LPMLs.
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Appendix A
Random effects approaches when X3 is
zero-inflated count data
In the setting of Chapter 2, the third variable X3 is zero-inflated count data. However,
in Chapter 4, to fit the setting of data set we used, we assume the third variable X3
follows a normal distribution. To model the dynamic correlation in zero-inflated
bivariate count data when X3 is also zero-inflated and count-based, more works are
needed to be done. In this Appendix, we briefly introduce two approaches that can
be used when X3 is zero-inflated count data.

A.1

ZENCO with Random Effects

The first approach is an direct extension of ZENCO in Chapter 2. Suppose there are
s different subjects. For kth subject, there are nk different cells. Let Xikj represent
the gene expression level of the ith gene (i = 1, 2, 3) in the jth cell (j = 1, 2, ...nk ) of
the kth subject(k = 1, 2, ..., s). The correlation, ρkj , of (Z1kj , Z2kj ) is specified as
log(

1 + ρkj
) = τ0k + τ1 X3kj .
1 − ρkj

(A.1)

1+ρ

kj
) is the Fisher’s Z-transformation for the correlation ρkj .
log( 1−ρkj

The distribution of τ0k is as follow:

τ0k ∼ N (τ0 , στ0 ), k = 1, 2...s

(A.2)

We simulated 50 subjects, each with 100 cells. The simulated data contain the
expression level of three genes: X1 , X2 , and X3 , and the indicator variable for different
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subjects. The simulated data have 5,000 rows and 4 columns. This simulation was
conducted as follows.
For each subject, a subject-specific τ0k was sampled from N (0, 1). Different values
of τ0k are correspond to different subjects. We then used the same simulation strategy
we used in ZENCO paper to simulate 100 cells for each subject. Since there are
50 subjects in total, the simulated data have 5,000 cells. The indicator variable
for different subjects was added as the forth column of the simulated data. The
mean squared errors (MSE), mean bias errors (MBE), and 95% empirical coverage
probabilities are presented in Table A.1.
Table A.1. Coverage probability of 95% credible intervals (CIs), interval lengths,
Mean square errors (MSE), and mean bias errors (MBE) based on 1,000 MCMC
simulations (τ0 = 0, τ1 = 0.05, 50 participants, 100 cells per participant) using
ZENCO with random effects.
Parameter
µ1
µ2
ϕ1
ϕ2
τ0
τ1

Coverage probability
0.946
0.944
0.943
0.951
0.960
0.951

CI length
2.356
2.356
0.672
0.667
1.054
0.044

MSE
0.366
0.382
0.030
0.028
0.066
0.000

MBE
-0.057
-0.075
-0.007
-0.003
-0.011
0.000

Moreover, according to Gelman (2006), we can also implement a redundant multiplicative re-parameterization to reduce autocorrelation and improve Markov Chain
Monte Carlo (MCMC) convergence:
τ0k ∼ N (τ0 + ξηk , στ0 ), k = 1, 2...s

(A.3)

ξ ∼ N (0, τξ )
ηk ∼ N (0, τη )
τη ∼ Gamma(0.5, 0.5)
In this setting, the variance of the random effect ξηk will follow a half-Cauchy distribution (Gelman, 2006).
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A.2

Copula Model with Random Effects

The second model is based on the Copula model in Ma et al. (2020). The MCMC
sampling scheme is described as follows:
1. Initiate η i = (µi , ϕi ), τ0 , στ0 , τ1 , τ0k , and {zkj }sk=1 , j = 1, . . . , nk . Set t = 1.
2. For i = 1, 2 and j = 1, . . . , nk ,
a) Calculate


f (zikj | z(−i)kj , else) = Φ



Φ−1 [Fi (xikj ; η i )] − ρkj z(−i)kj 

q

1 − ρ2kj

−



Φ



Φ−1 [Fi (xikj − 1; η i )] − ρkj z(−i)kj 

q

1 − ρ2kj

b) Sample


zikj ∼ N ρkj z(−i)kj , 1 − ρ2kj



truncated at (Φ−1 [Fi (xikj − 1; η i )], Φ−1 [Fi (xikj ; η i )]);
(t)

c) Sample η i from


f (ηη i |·) ∝ 



nk
s Y
Y

f (zikj | z(−i)kj , else) f (ηη i ),

k=1 j=1

where f (ηη i ) represents the prior distributions of η i .
3. Sample (τ1 , τ0k )(t) from


f (τ1 , τ0k |·) ∝ 

nk Y
nc
Y



f (zkj |τ1 , τ0k ) f (τ1 ) f (τ0k ),

k=1 j=1

4. Sample (τ0 , στ0 )(t) from
f (τ0 , στ0 |τ0k ) ∝ f (τ0k |τ0 , στ0 ) f (τ0 ) f (στ0 )
5. Set t = t + 1 and return to Step 2.
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;

A random-walk adaptive Metropolis algorithm (Haario et al., 2001) was used in
the above sampling scheme. In general, for a d-dimensional vector θ ∗ , to sample
θ ∗ ∼ MVN(θ (t−1) , Ct ) where

Ct =





C 0

t ≤ t0 ,

h
i



sd · cov(θ (t−h) , . . . , θ (t−1) ) + ϵ · Id

t > t0 ,

(A.4)

we accept θ (t) = θ ∗ with probability
ϕ(θ (t−1) |θ ∗ , Ct )
f (θ ∗ |·)
·
.
min 1,
f (θ (t−1) |·) ϕ(θ ∗ |θ (t−1) , Ct )
)

(

(A.5)

We tuned sd and ϵ to make the acceptance rate around 23%. Gelman et al. (1996)
recommend to set sd = 2.42 /d and ϵ = 0.005 to make sure that the acceptance rate
is optimal. In step 3, we want to sample τ1 and τ0k simultaneously. If we use the
recommended sd and ϵ for both of them to make sure the overall acceptance rate is
optimal, we can see their trace plots don’t show good mixing. Therefore, we tuned
sd and ϵ for τ1 and τ0k separately.
Using same simulation setting in ZENCO with random effects, we applied the
copula model with random effects and presented 95% empirical coverage probabilities,
MSE and MBE in Table A.2.
Table A.2. Coverage probability of 95% credible intervals (CIs), interval lengths,
Mean square errors (MSE), and mean bias errors (MBE) based on 1,000 MCMC
simulations (τ0 = 0, τ1 = 0.05, 20 participants, 500 cells per participants) using
Copula model with random effects.
Parameter
µ1
µ2
τ0
τ1
τy

Coverage probability
0.962
0.959
0.956
0.872
0.959

62

CI length
0.422
0.422
0.963
0.011
1.436

MSE
0.011
0.011
0.052
0.000
0.132

MBE
-0.002
-0.005
0.007
0.000
0.003

